Initial Results of Dose Escalation of ISB 1342, a Novel CD3xCD38 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)
暂无分享，去创建一个
G. Gudi | C. Huff | M. Mohty | A. Lesokhin | P. Moreau | C. Touzeau | A. Garton | D. Vesole | E. Feldman | J. Richter | L. Karlin | A. Perrot | K. Belhadj | J. Matous | S. Mohan | Y. Salhi | J. Berdeja | V. Menon | T. Chalopin | S. Gn | Cristiana Costa Chase | Igor Proscurshim | Eileen Wolff